XML 20 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 26, 2020
Dec. 28, 2019
Dec. 29, 2018
Revenues:      
Total revenue $ 40,127,669 $ 29,518,809 $ 24,465,005
Expenses:      
Cost of product revenues 21,398,381 20,901,538 15,831,441
Research and development-funded programs 7,745,762 4,216,161 4,892,066
Research and development-internal 3,924,241 9,132,969 12,553,237
Selling, general and administrative 11,822,703 21,316,459 27,210,849
Impairment of goodwill 331,344 1,417,470
Impairment of assets 2,526,669
Total operating expenses 44,891,087 55,898,471 64,431,732
Loss from operations (4,763,418) (26,379,662) (39,966,727)
Non-operating income (expense), net:      
Interest income 132,642 543,759 640,059
Other (expense) income, net (35,463) 225,617 855,106
Foreign currency transaction gains 293,670 202,517 1,169,254
(Loss) gain on investments (29,356) (3,858,453) 2,849,816
Total non-operating income (expense) 361,493 (2,886,560) 5,514,235
Loss before provision for income taxes and net loss (income) of noncontrolling interest (4,401,925) (29,266,222) (34,452,492)
Tax provision (129,000) (108,000) (30,000)
Net loss (4,530,925) (29,374,222) (34,482,492)
Net loss (income) attributable to the noncontrolling interest 119,813 (132,030) (51,050)
Net loss attributable to Kopin Corporation $ (4,411,112) $ (29,506,252) $ (34,533,542)
Net loss per share:      
Basic and diluted $ (0.05) $ (0.37) $ (0.47)
Weighted average number of common shares outstanding:      
Basic and diluted 82,347,741 80,282,126 73,156,545
Net Product Revenues [Member]      
Revenues:      
Total revenue $ 28,517,874 $ 20,283,888 $ 19,211,115
Research and Development and Other Revenues [Member]      
Revenues:      
Total revenue $ 11,609,795 $ 9,234,921 $ 5,253,890